Latest Funding News

Minerals 260 has secured a $59.1 million fixed-price contract with ATCO to build a 400-person accommodation village at its Bullabulling Gold Project, marking a key step towards construction readiness.

Cleo Diagnostics (ASX:COV) has hit a major milestone by completing sample collection for its pivotal U.S. ovarian cancer trial, while progressing manufacturing and analytical validation steps toward FDA 510(k) submission.

Caprice Resources has confirmed significant extensions of high-grade gold mineralisation at its Island Gold Project, backed by a $12.74 million capital raise and a new multi-rig drilling campaign.

Dundas Minerals has secured $2.5 million to fund extensive drilling across its Western Australian gold portfolio, exercised its option to acquire the Rockland mining lease, and expanded the Romano project with a new exploration licence application near Gruyere.

Horizon Gold has reported strong high-grade gold intercepts from drilling at its Omega and Kingfisher prospects in Western Australia, extending mineralisation and advancing its feasibility study on a 2.3 million ounce resource base.

Neometals Ltd has launched a 1-for-6 entitlement offer at A$0.04 per share alongside a two-tranche placement, targeting a combined A$13 million to advance gold and critical minerals projects.

West Wits Mining has poured its first gold at Qala Shallows, marking its transition to production, while securing substantial funding and advancing plans to scale output.

Andean Silver has delivered robust drilling results at Cerro Bayo, reinforcing resource continuity and growth prospects ahead of a June mineral resource update and ongoing restart studies.

Culpeo Minerals has restructured its Lana Corina earn-in deal to slash near-term cash outlays and plans a fully funded 4,000m diamond drilling campaign at Vista Montana in Q2 2026, while advancing its Fortuna copper project and streamlining its shareholder base.

CuFe Ltd has boosted confidence in its Orlando Copper-Gold Deposit by upgrading 87% of the resource to Indicated, paving the way for development studies and a substantial drilling campaign.

Victory Metals has reported record rare earth oxide grades and exceptional metallurgical results at its North Stanmore project, alongside strategic partnerships and heritage clearances that unlock exploration potential.

Actinogen Medical’s pivotal XanaMIA trial clears a key interim hurdle with the Data Monitoring Committee endorsing continuation, while a $16.8 million capital raise and non-dilutive funding bolster its balance sheet ahead of final results due November 2026.